RETRACTED: Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 5 (1) , 69-83
Abstract
No abstract availableKeywords
Funding Information
- Janssen Pharmaceutica
- National Institutes of Health
This publication has 49 references indexed in Scilit:
- Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challengesInternational Journal of Cardiology, 2013
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary EmbolismNew England Journal of Medicine, 2012
- Regulation of the Inflammatory Response in Cardiac RepairCirculation Research, 2012
- Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injuryJournal of Clinical Investigation, 2009
- Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overloadHistochemistry and Cell Biology, 2008
- Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 ActivationThe American Journal of Pathology, 2008
- Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and HypertrophyCirculation, 2007
- Protease-activated Receptor 2 in Colon CancerJournal of Biological Chemistry, 2004
- Protease-Activated Receptor-1–Mediated DNA Synthesis in Cardiac Fibroblast Is via Epidermal Growth Factor Receptor TransactivationCirculation Research, 2002